Amyloid imaging and cognitive decline in nondemented oldest-old: the 90+ Study
- PMID: 23164550
- PMCID: PMC3604036
- DOI: 10.1016/j.jalz.2012.06.005
Amyloid imaging and cognitive decline in nondemented oldest-old: the 90+ Study
Abstract
Background: The goal of this study was to examine cross-sectional and longitudinal associations between cognitive performance and beta amyloid (Aβ) load determined by florbetapir F18 positron emission tomography (PET) in nondemented oldest-old.
Methods: Thirteen nondemented (normal or cognitively impaired nondemented) participants (median age, 94.2 years) from The 90+ Study underwent florbetapir-PET scanning within 3 months of baseline neuropsychological testing. Amyloid load was measured with a semi-automated quantitative analysis of average cortical-to-cerebellar standardized uptake value ratio (SUVr) and a visual interpretation (Aβ- or Aβ+). Neuropsychological testing was repeated every 6 months.
Results: At baseline, SUVr correlated significantly with tests of global cognition and memory. During follow-up (median, 1.5 years), the Aβ+ group had steeper declines on most cognitive tests, particularly global cognitive measures.
Conclusion: This preliminary study suggests that greater amyloid load is associated with poorer cognition and faster cognitive decline in nondemented oldest-old. Amyloid load may identify individuals at increased risk of developing Alzheimer's disease.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.Neurology. 2012 Oct 16;79(16):1636-44. doi: 10.1212/WNL.0b013e3182661f74. Epub 2012 Jul 11. Neurology. 2012. PMID: 22786606 Free PMC article.
-
Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography.Am J Geriatr Psychiatry. 2013 Mar;21(3):272-8. doi: 10.1016/j.jagp.2012.11.016. Am J Geriatr Psychiatry. 2013. PMID: 23395194 Free PMC article.
-
Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.PLoS One. 2015 Jul 29;10(7):e0123743. doi: 10.1371/journal.pone.0123743. eCollection 2015. PLoS One. 2015. PMID: 26221954 Free PMC article. Clinical Trial.
-
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334. Brain. 2017. PMID: 28077397 Free PMC article.
-
Amyloid deposition, hypometabolism, and longitudinal cognitive decline.Ann Neurol. 2012 Oct;72(4):578-86. doi: 10.1002/ana.23650. Ann Neurol. 2012. PMID: 23109153 Free PMC article.
Cited by
-
Cerebral Perfusion Enhancing Interventions: A New Strategy for the Prevention of Alzheimer Dementia.Brain Pathol. 2016 Sep;26(5):618-31. doi: 10.1111/bpa.12405. Brain Pathol. 2016. PMID: 27324946 Free PMC article. Review.
-
The evolution of preclinical Alzheimer's disease: implications for prevention trials.Neuron. 2014 Nov 5;84(3):608-22. doi: 10.1016/j.neuron.2014.10.038. Epub 2014 Nov 5. Neuron. 2014. PMID: 25442939 Free PMC article. Review.
-
Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.Alzheimers Dement. 2016 Jul;12(7):805-14. doi: 10.1016/j.jalz.2015.12.009. Epub 2016 Jan 21. Alzheimers Dement. 2016. PMID: 26806386 Free PMC article.
-
Cortico-limbic volume abnormalities in late life depression are distinct from β amyloid and white matter pathologies.Mol Psychiatry. 2025 Apr;30(4):1267-1276. doi: 10.1038/s41380-024-02677-4. Epub 2024 Nov 7. Mol Psychiatry. 2025. PMID: 39511448
-
The Future for Dementia Research: a Perspective from the Journal of Molecular Neuroscience.J Mol Neurosci. 2016 Nov;60(3):410-411. doi: 10.1007/s12031-016-0841-5. J Mol Neurosci. 2016. PMID: 27647306 No abstract available.
References
-
- Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of neurology. 2004;55:306–319. - PubMed